05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
Safety has always been a challenge on construction sites, but the coronavirus pandemic has made main...
Read More >
On December 12, 2019, for the first time in 60 years, the U.S. Department of Labor (DOL) announced a...
Read More >
Seyfarth Synopsis: As part of Governor Cuomo’s New York Forward plan, “Phase One” industries in f...
Read More >
On July 18, 2019, the U.S. District Court for the Eastern District of Pennsylvania granted a defenda...
Read More >
On 31 December 2019, a new coronavirus disease, now officially named “Covid-19”, was first reporte...
Read More >
On Thursday, February 6, 2020, the Third Circuit Court of Appeals issued an order upholding Philadel...
Read More >